Harnessing oncolytic viruses to overcome immunosuppression in breast cancer: from mechanisms to clinical translation
Oncolytic viruses (OVs) possess dual advantages in cancer immunotherapy: they selectively replicate within and lyse tumor cells while simultaneously releasing tumor-associated antigens to recruit and activate immune cells within the local tumor microen…